Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Beauty Health ( (SKIN) ) is now available.
On October 1, 2025, Pedro Malha will assume the role of President and CEO of The Beauty Health Company, succeeding Marla Beck, who will transition to an advisory role. Malha’s extensive experience in the healthcare and medical device sectors positions him to lead the company into its next growth phase, building on Beck’s efforts to enhance innovation and operational efficiency.
The most recent analyst rating on (SKIN) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
The overall stock score reflects significant financial challenges, including high leverage and negative profit margins. However, positive developments from the earnings call, such as improved margins and strategic debt restructuring, provide some optimism. Technical indicators suggest a bearish trend, and valuation metrics highlight ongoing financial difficulties.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company (NASDAQ: SKIN) operates at the intersection of medtech and beauty, offering skin health experiences through brands like Hydrafacial™, SkinStylus™, and Keravive™. The company focuses on personalizing skin health for diverse demographics, supported by a global community of estheticians and partners.
Average Trading Volume: 1,083,310
Technical Sentiment Signal: Buy
Current Market Cap: $253.7M
For a thorough assessment of SKIN stock, go to TipRanks’ Stock Analysis page.